Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types
Abstract Acute myocardial infarction and chronic heart failure rank among the major causes of morbidity and mortality worldwide. Except for heart transplantation, current therapy options only treat the symptoms but do not cure the disease. Stem cell-based therapies represent a possible paradigm shif...
Main Authors: | Elena Cambria, Francesco S. Pasqualini, Petra Wolint, Julia Günter, Julia Steiger, Annina Bopp, Simon P. Hoerstrup, Maximilian Y. Emmert |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | npj Regenerative Medicine |
Online Access: | https://doi.org/10.1038/s41536-017-0024-1 |
Similar Items
-
Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment
by: Julia Günter, et al.
Published: (2016-01-01) -
3D-microtissue derived secretome as a cell-free approach for enhanced mineralization of scaffolds in the chorioallantoic membrane model
by: Lukas Otto, et al.
Published: (2021-03-01) -
Training the next generation of pluripotent stem cell researchers
by: Schwartz Philip
Published: (2008-07-01) -
Training the Next Generation of Translational Cardiovascular Investigators
by: Jeanne M. Nerbonne, PhD, et al.
Published: (2016-10-01) -
Comparison of NOGA endocardial mapping and cardiac magnetic resonance imaging for determining infarct size and infarct transmurality for intramyocardial injection therapy using experimental data.
by: Noemi Pavo, et al.
Published: (2014-01-01)